MedSource Labs launches Passivo passive safety IV catheter

MedSource Labs has launched Passivo, a passive safety peripheral IV catheter that received FDA 510(k) clearance and adds a new automatic safety option for U.S. clinicians. The product expands the company’s IV catheter lineup as hospitals look for safer, more efficient vascular access tools.

Why it matters: - Passivo gives U.S. clinicians a passive safety peripheral IV catheter option that automatically covers the needle tip after withdrawal. - The launch matters because an estimated 90% of patients admitted to U.S. hospitals receive an IV during treatment. - MedSource Labs is positioning the product as a cost-effective vascular access device with safety features built for high-volume hospital use.

What happened: - MedSource Labs launched Passivo, a passive safety peripheral IV catheter, on July 30, 2026. - Passivo received FDA 510(k) clearance before its U.S. debut. - The catheter is known as PurSafe in international markets and is being renamed for the U.S. launch. - The launch completes MedSource Labs’ portfolio of active and safety peripheral IV catheters.

The details: - Passivo uses sharp needles paired with gently tapered catheters to reduce force and trauma to the vein and skin. - The catheter includes a passive safety clip that automatically covers the needle tip upon withdrawal. - The design includes a one-handed grip that allows clinicians to place IVs with one hand. - That setup frees the other hand to steady the patient, secure tape, and begin immediate fluid administration. - Rachel Sender, senior vice president of product management, said FDA 510(k) clearance is a multi-year process designed to ensure reliability and clinician and patient safety. - Todd Fagley, founder and CEO of MedSource Labs, said the passive safety mechanism gives customers access to every major style of peripheral IV catheter available in the United States.

Between the lines: - MedSource Labs has long sold active safety peripheral IV catheters that require a clinician to activate the safety mechanism manually. - Passivo adds an automatic alternative, which may appeal to customers seeking simpler workflow and fewer activation steps. - The U.S. launch also signals a broader push to round out MedSource Labs’ vascular access lineup.

What's next: - MedSource Labs is directing clinicians and buyers to more information on Passivo. - The company will continue marketing Passivo as part of its U.S. IV therapy portfolio.

The bottom line: - Passivo gives MedSource Labs a passive safety IV catheter in the U.S. market and closes a gap in its peripheral catheter lineup.